Drug Store News Reports More M&A Coming In CBD Industry, Names CBD Unlimited To Its ‘Who’s Who In CBD 2020’ List
This week (April 15, 2020) B2B publication Drug Store News (DSN) published an article that the consolidation of the CBD industry would continue, citing industry experts saying that there would be more acquisitions. It also named CBD Unlimited Inc. to (OTC PINK: EDXC) to its “Who’s Who In CBD 2020” list among other leading CBD companies. It said that CBD Unlimited, Inc. is doubling its number of topicals products it markets and is adding two more ingestible products, hemp-infused chocolates and honey sticks.
The CBD market has drawn intense interest from media companies. stockmarketpress.com features specialized coverage of CBD related stocks such as CBD Unlimited, Inc. (OTC PINK: EDXC), Canopy Growth Corp. (NYSE: CGC), New Age Beverages Corp. (NASDAQ: NBEV), GW Pharmaceuticals PLC (NASDAQ: GWPH), Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT). Aurora Cannabis Inc. (NYSE:ACB) (TSX: ACB), Supreme Cannabis Co. (OTC: SPRWF) and OrganiGram Holdings Inc. (NASDAQ: OGI).
Drug Store News Reports More M&A Coming In CBD Industry, Names CBD Unlimited (OTC PINK: EDXC) To Its ‘Who’s Who In CBD 2020’ List
In naming CBD Unlimited Inc. to (OTC PINK: EDXC) to its “Who’s Who In CBD 2020” list this week, DSN also described the company’s line of oils, capsules, topicals and pet products, focused on providing therapeutic and pain relief to humans and pets. The roundup article also names industry experts as saying that the round of acquisitions/consolidation within the CBD industry would continue. Drug Store News Reports More M&A Coming In CBD Industry, Names CBD Unlimited (OTC PINK: EDXC) To Its ‘Who’s Who In CBD 2020’ List.
Acquiring Companies Include: Charlotte’s Web, Colgate Palmolive, PepsiCo And CBD Unlimited, Inc.
Recently, the M&A activity in the CBD industry includes the move by Charlotte’s Web (NASDAQ: CWBHF), marketer of hemp-derived CBD products, to buy Abacus Health Products (CSE: ABCS), a leader in OTC hemp extract topicals. It will result in a new entity with an estimated $190 million in sales in 2020 and a market cap of some $450 million. Also, mainstream firm Colgate Palmolive (NYSE: CL) acquired Hello Products and its line of oral hygiene products — CBD-infused toothpastes, toothbrushes, mouthwashes and lip balms. Colgate Palmolive is a trusted, mainstream and established brand. Its entry into CBD-infused product in the oral hygiene area raises the profile of CBD on the shelf.
PepsiCo (NASDAQ: PEP) is buying Rockstar Energy Drink to solidify its place in the functional beverage market. CBD Unlimited, Inc. (OTC PINK: EDXC) joined the CBD M&A activity by buying Kush, Inc. M&A activity in CBD market is a smart strategy to grow market sales and market cap, industry insiders say. Drug Store News Reports More M&A Coming In CBD Industry, Names CBD Unlimited (OTC PINK: EDXC) To Its ‘Who’s Who In CBD 2020’ List.
CBD Unlimited Inc. (OTC PINK: EDXC) Named In ‘Who’s Who In CBD 2020’ By Drug Store News
The DSN roundup feature not only highlighted CBD Unlimited Inc. (OTC PINK: EDXC) for its new products, but it also described the company’s line of oils, capsules, topicals and pet products, all focused on therapeutic and pain relief for humans and pets. The DSN article also named: Charlotte’s Web (NASDAQ: CWBHF) (which recently acquired Abacus Health Products (OTC: ABAHF), The Alkaline Water Company (NASDAQ: WTER), cbdMD (NYSE: YCBD) and CV Sciences (OTC: CVSI), among others. Drug Store News Reports More M&A Coming In CBD Industry, Names CBD Unlimited (OTC PINK: EDXC) To Its ‘Who’s Who In CBD 2020’ List.
CBD Unlimited Inc. (OTC PINK: EDXC) Projects Greater Than Tripling Product Placement To 200,000+ Stores In 3-5 Years
CBD Unlimited Inc. (OTC PINK: EDXC) inclusion in DSN’s “Who’s Who In CBD 2020” roundup article comes at a time of expansion for the company. Just this week CBD Unlimited Inc. (OTC PINK: EDXC) announced it was projecting that it will more than triple its product placement from the current 60,000 stores to more than 200,000+ in 3-5 years as part of an aggressive new distribution program with an early stage roll out beginning in Q3. It focuses growth in the pharmaceutical and grocery/natural food channels as well as independents. Mass market pharmacy is a specialty retail segment covered by DSN, and CBD Unlimited Inc. (OTC PINK: EDXC) is extending its retail distribution within that retail channel.
Todd Davis, CEO of CBD Unlimited, Inc., (OTC PINK: EDXC) addressed the company’s new distribution program: “The aggressive positioning from our distributors and phenomenal cooperation with retail accounts has made it possible for us to project retail door count opportunities to increase from 60,000 stores to estimates of over 200,000 stores, which include retail distribution points, over the next 3-5 years.”
CBD Unlimited, Inc.’s (OTC PINK: EDXC) 101% Sales Increase
The company recently reported it reached sales of $1+ Million in Q2 this year, the three months ending March 31. CBD Unlimited (OTC PINK: EDXC) had reported significant growth performance in 2019 when it announced a 101% annual increase in revenues and is on track to continue its upward growth trajectory and surpass year-over-year guidance and goals.
Davis of CBD Unlimited, Inc. (OTC PINK: EDXC) discussed in a NASDAQ MarketSite interview with reporter Jane King the company’s aggressive sales plans. The interview can be seen and heard on a YouTube video online. He also talks about the company’s sales strategy overseas.
CBD Unlimited, Inc. (OTC PINK: EDXC) Carefully Controls Product Quality
CBD Unlimited, Inc. (OTC PINK: EDXC) ensures that its CBD product is monitored every step of the way: from U.S. hemp growing, processing and marketing. A seed-to-shelf strategy ensured the company carefully controls its product quality and consistency. The consumer can be confident of the brand and investors in the company can be assured of its attention to controlling product quality, producing CBD products from hemp sourced and grown in Colorado and Kentucky under USDA and state regulations.
CBD Unlimited, Inc. (OTC PINK: EDXC) develops and distributes all-natural CBD products derived from hemp. Its portfolio of products includes oils, capsules, topicals for humans and specially formulated pet products. Phyto-Bites are soft chews for animal use designed to reduce inflammation, pain and separation-anxiety The company’s CBD hemp product has premium genetics and superior quality. The extracts in its products are rich in phyto-cannabinoids and terpenoids that are non-psychoactive.
Source: Stock Market Press
Join Stock Market Press’ newsletter for the latest in IPO, market commentary and company profiles.
Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.
Stock Market Press
110 Wall St.
New York, NY 10005 email@example.com Safe Harbor Statement:
Statements in this news release may be ”forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Stock Market Press undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.
See Stock Market Press disclaimer: https://stockmarketpress.com/disclaimer/ SOURCE: Stock Market Press